• Nene's SAA nemesis

    No political figure seems to have the guts to speak out against Dudu Myeni, says Solly Moeng.

  • The mp3 revolution

    Ian Mann takes a look at the war between digital music and the compact disc.

  • Don't take us for fools

    It's time for businesses to stop thinking consumers are gullible, says Mandi Smallhorne.

All data is delayed
See More

Cipla Medpro's India deal on hold

Feb 11 2013 13:16
Johannesburg - The acting chief executive officer of Cipla Medpro said on Monday the generic drug firm has not received any communication from its Indian suitor, Cipla that an acquisition deal has been put on hold.

India's Economic Times, citing the chairperson of Cipla, reported on Monday that Cipla's $215m bid for control of the South African company is on hold.

"I am aware of the that report but I have not been able to verify it and we have not received any communication from Cipla about its withdrawal from the talks," Johan du Preez, Cipla Medpro's acting CEO, told Reuters.

"As far as we are concerned, the talks are ongoing." 

Shares in Cipla Medpro fell 5.32% to R8.90, still above the R8.55 Cipla put on the table in November. 

Follow Fin24 on Twitter, Facebook, Google+ and Pinterest.

pharmaceutical industry



Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Company Snapshot

We're talking about:


Marketing is a big concern in SA's small business community, followed by a lack of confidence and partnering with the wrong people, according to a survey.

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

The 25 basis points interest rate increase is:

Previous results · Suggest a vote